Related Experiment Video

Updated: Aug 4, 2026

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
18:10

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency

Published on: June 16, 2011

Clinical review of ribavirin

M Eggleston

    Infection Control : IC
    |May 1, 1987
    PubMed

    Insights

    Ribavirin aerosol is now approved for treating severe respiratory syncytial virus (RSV) in young children, effectively reducing symptoms and viral shedding. Further research is needed for other viral infections like hepatitis and influenza.

    Area of Science:

    • Virology
    • Pediatric Infectious Diseases
    • Pharmacology

    Background:

    • Respiratory syncytial virus (RSV) is a common cause of severe respiratory illness in infants and young children.
    • Antiviral therapies for RSV have been limited, necessitating new treatment options.

    Purpose of the Study:

    • To evaluate the efficacy and administration of aerosolized ribavirin for severe RSV infections.
    • To explore the potential of ribavirin in treating other viral infections.

    Main Methods:

    • Administration of ribavirin as an aerosol via face mask or mist tent for 20-21 hours daily.
    • Clinical assessment of symptom reduction and viral shedding in RSV-infected infants and children.
    • Review of studies investigating ribavirin for viral hepatitis, influenza, Lassa fever, herpes simplex, and herpes zoster.

    Main Results:

    • Aerosolized ribavirin significantly decreased RSV symptoms and viral shedding in pediatric patients.
    • Promising but inconclusive results were observed for ribavirin in treating other viral infections.
    • Further studies are required to establish ribavirin's efficacy for these additional indications.

    Conclusions:

    • Aerosolized ribavirin represents a significant advancement in treating severe RSV in infants and young children.
    • Ribavirin shows potential for other viral diseases, but more research is essential.
    • The approved use of ribavirin aerosol expands antiviral treatment options for critical pediatric respiratory infections.

    More Related Videos

    High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

    High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

    Published on: May 5, 2014

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

    Published on: June 26, 2020

    Related Concept Videos

    Diseases of the Liver and Gallbladder01:26

    Diseases of the Liver and Gallbladder

    Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
    Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
    Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

    Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

    Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Antiviral Nucleoside Inhibitors01:22

    Antiviral Nucleoside Inhibitors

    Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...